Evidence map›Paper›PMID 28539798›Full record

ReviewEye and brain2016

Progress in the clinical development and utilization of vision prostheses: an update.

Alice Brandli, Chi D Luu, Robyn H Guymer, Lauren N Ayton

Open access · goldAbstract readReview
In one paragraph

Review in Eye and brain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The Use of Electrotherapeutics in Ophthalmology.American journal of ophthalmology · 2020
    Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alice BrandliCentre for Eye Research Australia, Department of Surgery (Ophthalmology), The University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Chi D LuuCentre for Eye Research Australia, Department of Surgery (Ophthalmology), The University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Robyn H GuymerCentre for Eye Research Australia, Department of Surgery (Ophthalmology), The University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Lauren N AytonCentre for Eye Research Australia, Department of Surgery (Ophthalmology), The University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
University of Melbourne · AUCentre for Eye Research Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vision prostheses, or "bionic eyes", are implantable medical bionic devices with the potential to restore rudimentary sight to people with profound vision loss or blindness. In the past two decades, this field has rapidly progressed, and there are now two commercially available retinal prostheses in the US and Europe, and a number of next-generation devices in development. This review provides an update on the development of these devices and a discussion on the future directions for the field.

Indexed as

bionic eyeblindnessmedical bionicsretinitis pigmentosavision prosthesesvision restoration

Identifiers

PMID28539798
PMCPMC5398739
OpenAlexW2382071288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.